101 related articles for article (PubMed ID: 21670604)
1. Spinophilin loss contributes to tumorigenesis in vivo.
Ferrer I; Peregrino S; Cañamero M; Cecilia Y; Blanco-Aparicio C; Carnero A
Cell Cycle; 2011 Jun; 10(12):1948-55. PubMed ID: 21670604
[TBL] [Abstract][Full Text] [Related]
2. Spinophilin: a new tumor suppressor at 17q21.
Carnero A
Curr Mol Med; 2012 Jun; 12(5):528-35. PubMed ID: 22515982
[TBL] [Abstract][Full Text] [Related]
3. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
Ferrer I; Blanco-Aparicio C; Peregrina S; Cañamero M; Fominaya J; Cecilia Y; Lleonart M; Hernandez-Losa J; Ramon y Cajal S; Carnero A
Cell Cycle; 2011 Aug; 10(16):2751-62. PubMed ID: 21772120
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
Molina-Pinelo S; Ferrer I; Blanco-Aparicio C; Peregrino S; Pastor MD; Alvarez-Vega J; Suarez R; Verge M; Marin JJ; Hernandez-Losa J; Ramon y Cajal S; Paz-Ares L; Carnero A
J Pathol; 2011 Sep; 225(1):73-82. PubMed ID: 21598252
[TBL] [Abstract][Full Text] [Related]
5. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
Ferrer I; Verdugo-Sivianes EM; Castilla MA; Melendez R; Marin JJ; Muñoz-Galvan S; Lopez-Guerra JL; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Perez M; Palacios J; Carnero A
Oncogene; 2016 May; 35(21):2777-88. PubMed ID: 26387546
[TBL] [Abstract][Full Text] [Related]
6. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
Estevez-Garcia P; Lopez-Calderero I; Molina-Pinelo S; Muñoz-Galvan S; Salinas A; Gomez-Izquierdo L; Lucena-Cacace A; Felipe-Abrio B; Paz-Ares L; Garcia-Carbonero R; Carnero A
Clin Cancer Res; 2013 Jul; 19(14):3925-35. PubMed ID: 23729363
[TBL] [Abstract][Full Text] [Related]
7. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
[No Abstract] [Full Text] [Related]
8. Tumor suppression by Spinophilin.
Santamaría D; Malumbres M
Cell Cycle; 2011 Sep; 10(17):2831-2. PubMed ID: 21869595
[No Abstract] [Full Text] [Related]
9. SPINOPHILIN: A multiplayer tumor suppressor.
Verdugo-Sivianes EM; Carnero A
Genes Dis; 2023 Jan; 10(1):187-198. PubMed ID: 37013033
[TBL] [Abstract][Full Text] [Related]
10. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
11. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
[TBL] [Abstract][Full Text] [Related]
12. Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.
Zander SA; Kersbergen A; Sol W; Gonggrijp M; van de Wetering K; Jonkers J; Borst P; Rottenberg S
Cancer Prev Res (Phila); 2012 Aug; 5(8):1053-60. PubMed ID: 22767648
[TBL] [Abstract][Full Text] [Related]
13. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
Kuperwasser C; Hurlbut GD; Kittrell FS; Dickinson ES; Laucirica R; Medina D; Naber SP; Jerry DJ
Am J Pathol; 2000 Dec; 157(6):2151-9. PubMed ID: 11106587
[TBL] [Abstract][Full Text] [Related]
14. [When the curtain goes up on spinophilin's tumor suppressor function].
Sarrouilhe D; Ladeveze V
Med Sci (Paris); 2012 Jan; 28(1):26-8. PubMed ID: 22289823
[No Abstract] [Full Text] [Related]
15. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
16. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
17. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M
Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202
[TBL] [Abstract][Full Text] [Related]
18. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
19. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
